Comandella M G, Rossi M, Finco C, Pittoni G, Pianalto S, Cadamuro M C, Ferrari M, Ancona E, Cartei G
Istituto di Semeiotica Chiurgica, Università degli Studi di Padova.
G Chir. 1993 Mar;14(3):185-9.
The availability of a long-term central venous access for the management of neoplastic and chronic patients is extremely important in order to achieve an easy and safe infusion of chemotherapeutic drugs, blood components, and parenteral nutrition. The authors evaluated 26 adult patients (25 with malignant tumors and 1 with severe asthma) in whom implantable catheter systems were placed subcutaneously between February 1989 and March 1992. Catheters were inserted through the cephalic vein in 13 cases, the subclavia vein in 8 cases and jugular vein in 5 cases. The mean function time was 262 days in deceased patients and 155 in alive ones. There were no infective or thromboembolic complications. The authors, in agreement with the literature, confirm that TIS represent a safe and easy access for a long term i.v. therapy, with a very low complication rate. Furthermore, comfort of the patients is substantially improved and nursing care is greatly facilitated.
为了实现化疗药物、血液成分和肠外营养的轻松、安全输注，长期中心静脉通路对于肿瘤患者和慢性病患者的治疗极为重要。作者评估了1989年2月至1992年3月间皮下植入可植入式导管系统的26例成年患者（25例患有恶性肿瘤，1例患有严重哮喘）。13例通过头静脉插入导管，8例通过锁骨下静脉插入，5例通过颈静脉插入。死亡患者的平均使用时间为262天，存活患者为155天。未发生感染或血栓栓塞并发症。作者与文献一致，证实可植入式导管系统是长期静脉治疗的一种安全、简便的通路，并发症发生率极低。此外，患者的舒适度显著提高，护理工作也大大便利。
